Publication

Article

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter 09-02-2020
Volume15
Issue 9

Swittons Introduces IoT-Enabled Smart Devices for Pharmaceutical Labs

With the ability to be uniquely programmed, the devices provide user interfaces that can integrate with other systems and IoT devices, giving labs the ability to create their own Lab of the Future initiatives.

Swittons, a P360 company, introduced a new line of Internet of Things (IoT)-enabled smart devices for pharmaceutical labs. The devices work to automate laboratory workflows between people and existing digital lab equipment, systems, and solutions.

With the ability to be uniquely programmed, the devices provide user interfaces that can integrate with other systems and IoT devices, giving labs the ability to create their own Lab of the Future initiatives. Additionally, the new devices are compatible with laboratory information management systems, eDOC, and ticketing systems and feature a backend portal and reporting system.

“There are profound changes taking place in the area of life science research and development,” said Anupam Nandwana, Swittons’ CEO and founder, in an Aug. 11, 2020 company press release. “Driven by technological advances and the development of precision medicines, these modernization initiatives are designed to propel laboratory efficiencies into the future, allowing scientists to spend more time on science. This has changed the very concept of what the lab is, and Swittons is a key part of that evolution.”

Source: Swittons

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More